Quantcast
Last updated on April 19, 2014 at 6:57 EDT

Latest Rights issue Stories

2014-04-07 16:25:06

Company announces commencement of $45,000,000 rights offering to fund product commercialization efforts TUCSON, Ariz., April 7, 2014 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections, announced today that it has commenced a $45,000,000 rights offering to fund its product commercialization efforts. Under the terms of the...

2014-03-24 16:24:48

IRVINE, Calif., March 24, 2014 /PRNewswire/ -- PRO-DEX, INC. (NasdaqCM: PDEX) today announced that the registration statement for its previously announced common stock rights offering was declared effective as of March 21, 2014 by the Securities and Exchange Commission (the "SEC"). http://photos.prnewswire.com/prnvar/20111025/LA93174LOGO-c On December 17, 2013, Pro-Dex filed a registration statement on Form S-3 with the SEC with respect to the rights offering, which was...

2014-03-10 16:32:57

IRVINE, Calif., March 10, 2014 /PRNewswire/ -- PRO-DEX, INC. (NasdaqCM: PDEX) today announced that a record date of March 20, 2014 (the "Record Date") has been set for the Company's planned rights offering (the "Rights Offering"). On December 17, 2013, Pro-Dex filed a registration statement on Form S-3 with the Securities and Exchange Commission (the "SEC") with respect to the Rights Offering, which was subsequently amended via Amendment No.1 to Form S-3, filed with the SEC on March...

2014-02-12 20:21:55

RIVER EDGE, N.J., Feb. 12, 2014 /PRNewswire/ -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced today that it has commenced its previously disclosed rights offering. On February 12, 2014, the Company will distribute to holders of its common stock and/or warrants one non-transferable subscription right for each share of common stock, and each share of common stock underlying a warrant,...

2013-12-17 16:24:00

IRVINE, Calif., Dec. 17, 2013 /PRNewswire/ -- Pro-Dex, Inc. (NasdaqCM: PDEX) today announced that it has filed a Registration Statement on Form S-3 with the Securities and Exchange Commission (the "SEC") for a rights offering to existing holders of its common stock. Upon completion of the rights offering, the Company expects to receive gross proceeds of approximately $3,000,000 before expenses, subject to the Company's right to reduce the rights offering in order to preserve certain...

2013-10-29 16:24:24

LAS VEGAS, Oct. 29, 2013 /PRNewswire/ -- Caesars Entertainment Corporation ("Caesars") (NASDAQ: CZR) announced that in connection with the previously announced offering of Class A common stock of Caesars Acquisition Company ("CAC") to holders of subscriptions rights that were distributed by Caesars on October 21, 2013, affiliates of Apollo Global Management, LLC (together with its affiliates, "Apollo") and TPG Global, LLC (together with its affiliates, "TPG" and, together with Apollo, the...

2013-08-13 12:26:39

TUCSON, Ariz., Aug. 13, 2013 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX), announced today that it has completed its previously announced rights offering. Through broad participation from both insiders and non-insider investors, the Company raised $20,000,000, including proceeds from a standby commitment made by Abeja Ventures, LLC. Stockholders subscribed for a total of 1,871,410 shares of the Company's common stock pursuant to their basic subscription...

2013-07-12 08:23:33

Company previously announced plans to raise $20,000,000 to fund product commercialization efforts TUCSON, Ariz., July 12, 2013 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections, announced today the final terms of its previously announced $20,000,000 rights offering. The Company anticipates that the rights offering will...

2013-06-28 16:21:35

PRINCETON, N.J., June 28, 2013 /PRNewswire/ -- AMREP Corporation (the "Company") (NYSE:AXR) has successfully completed its rights offering, which closed at 5:00 PM New York City time on June 27, 2013. The rights offering allowed existing shareholders of the Company to purchase an aggregate of 1,199,242 shares of the Company's common stock at $6.25 per share. Rights were issued to shareholders of record as of May 31, 2013. Preliminary results indicate that the rights offering was...

2013-06-04 08:28:12

Company to raise $20,000,000 to fund business plan and product commercialization efforts TUCSON, Ariz., June 4, 2013 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections, today announced that it has filed a Registration Statement on Form S-3 with the Securities and Exchange Commission (the "SEC") for a rights offering to...